Washington University School of Medicine
Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.
Prostate Cancer
MRI with DBSI analysis
NA
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 500 participants |
| Masking : | SINGLE |
| Masking Description : | -Dr. Kim will be blinded to the DBSI results at the time of biopsy, but will have the conventional MRI interpretation available |
| Primary Purpose : | DIAGNOSTIC |
| Official Title : | Diffusion Basis Spectrum Imaging of the Prostate: A Virtual Biopsy to Accurately Diagnose Prostate Cancer |
| Actual Study Start Date : | 2020-02-27 |
| Estimated Primary Completion Date : | 2027-05-31 |
| Estimated Study Completion Date : | 2027-05-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | MALE |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Washington University School of Medicine
St Louis, Missouri, United States, 63110